WITH foresight of pharmacy prescribing in the works to come, Arrotex Pharmaceuticals has launched a new medical sales team in the hope of positioning Arrotex as Australia's largest sales team across both pharmacies and prescribers in the industry.
According to Arrotex's Chairman and CEO, Dennis Bastas, the new Arrotex Medical Services Division reflects the company's diverse and evolving product portfolio.
"I am thrilled to introduce the Arrotex Medical Services Division as a new capability for our company, enabling our continued growth and investment in this competitive industry," Bastas said.
"We recognise how essential prescribers are in the provision of integrated patient-centric care.
"Our dedicated Arrotex medical team will support prescribers in educating and empowering patients to understand treatment regimens in a bid to improve equitable access to medications," explained Bastas.
Executive GM for Pharmaceuticals Hayley Tamborini said the expertise and experience of the Arrotex medical team will allow the company to hit the ground running.
"Prescribers play a central role in the delivery of healthcare to the Australian community, and the Arrotex medical team will strive to help support the quality use of medicines from diagnosis through to prescription," Tamborini said.
The full Arrotex medical sales team, (pictured L-R), Andrew Scott, Regional Manager Biologics NSW/SA/WA; Lesley McMenamin, Head of Sales Arrotex Medical; Hayley Tamborini, Executive General Manager Arrotex Pharmaceuticals; Darrin Nichols, Regional Sales Manager NSW/ACT; Renata Gizzatullina, Regional Manager Biologics VIC/QLD; Andrew Cuttle, Regional Sales Manager QLD/WA; and absent Nerida Robinson, Regional Sales Manager VIC/SA.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Feb 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Feb 23
